Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.953 USD | -1.07% | -17.52% | -30.67% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.67% | 186M | |
-3.30% | 102B | |
+1.78% | 96.84B | |
-0.44% | 21.48B | |
-18.34% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.87% | 13.78B | |
+0.58% | 13.4B | |
+20.95% | 11.06B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Morgan Stanley Adjusts Price Target on bluebird bio to $10 From $11, Maintains Underweight Rating